InMed Pharmaceuticals (INM) Inventory (2021 - 2025)

InMed Pharmaceuticals has reported Inventory for 5 years, with the latest figure at $947898.0 in Q4 2025.

• For the quarter ending Q4 2025, Inventory fell 14.09% year-over-year to $947898.0; the trailing twelve-month figure through Dec 2025 stood at $947898.0 (down 14.09% YoY), and the FY2025 full-year result was $961173.0, down 22.76% from the prior year.
• Inventory for Q4 2025 stood at $947898.0, up from $890807.0 in the prior quarter.
• The five-year high for Inventory was $2.5 million in Q2 2022, with the low at $744839.0 in Q4 2023.
• Historically, Inventory has averaged $1.3 million across 5 years, with a median of $1.2 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory soared 63.17% — and 2023, when it sank 53.84%.
• InMed Pharmaceuticals' Inventory stood at $988822.0 in 2021, then soared by 63.17% to $1.6 million in 2022, then slumped by 53.84% to $744839.0 in 2023, then jumped by 48.13% to $1.1 million in 2024, then decreased by 14.09% to $947898.0 in 2025.
• The last three Inventory figures came in at $947898.0 (Q4 2025), $890807.0 (Q3 2025), and $961173.0 (Q2 2025), per Business Quant data.